Does IBRUTINIB Cause Squamous cell carcinoma? 163 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 163 reports of Squamous cell carcinoma have been filed in association with IBRUTINIB (Imbruvica). This represents 0.2% of all adverse event reports for IBRUTINIB.
163
Reports of Squamous cell carcinoma with IBRUTINIB
0.2%
of all IBRUTINIB reports
25
Deaths
39
Hospitalizations
How Dangerous Is Squamous cell carcinoma From IBRUTINIB?
Of the 163 reports, 25 (15.3%) resulted in death, 39 (23.9%) required hospitalization, and 12 (7.4%) were considered life-threatening.
Is Squamous cell carcinoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IBRUTINIB. However, 163 reports have been filed with the FAERS database.
What Other Side Effects Does IBRUTINIB Cause?
Death (8,007)
Off label use (5,446)
Fatigue (4,479)
Diarrhoea (3,903)
Atrial fibrillation (3,671)
Pneumonia (3,015)
Incorrect dose administered (2,752)
Contusion (2,712)
Fall (2,375)
Asthenia (2,200)
What Other Drugs Cause Squamous cell carcinoma?
ADALIMUMAB (456)
RUXOLITINIB (413)
TACROLIMUS (327)
INFLIXIMAB (313)
RITUXIMAB (313)
LENALIDOMIDE (304)
PREDNISONE (267)
RANITIDINE (260)
CYCLOSPORINE (254)
METHOTREXATE (252)
Which IBRUTINIB Alternatives Have Lower Squamous cell carcinoma Risk?
IBRUTINIB vs IBUPROFEN
IBRUTINIB vs IBUPROFEN LYSINE
IBRUTINIB vs IBUPROFEN UNKNOWN PRODUCT
IBRUTINIB vs IBUPROFEN\IBUPROFEN
IBRUTINIB vs IBUPROFEN\PHENYLEPHRINE